1. Home
  2. PSNL vs VBNK Comparison

PSNL vs VBNK Comparison

Compare PSNL & VBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSNL
  • VBNK
  • Stock Information
  • Founded
  • PSNL 2011
  • VBNK 1980
  • Country
  • PSNL United States
  • VBNK Canada
  • Employees
  • PSNL N/A
  • VBNK N/A
  • Industry
  • PSNL Medical Specialities
  • VBNK Commercial Banks
  • Sector
  • PSNL Health Care
  • VBNK Finance
  • Exchange
  • PSNL Nasdaq
  • VBNK Nasdaq
  • Market Cap
  • PSNL 321.1M
  • VBNK 381.9M
  • IPO Year
  • PSNL 2019
  • VBNK 2021
  • Fundamental
  • Price
  • PSNL $3.89
  • VBNK $16.49
  • Analyst Decision
  • PSNL Strong Buy
  • VBNK Strong Buy
  • Analyst Count
  • PSNL 4
  • VBNK 3
  • Target Price
  • PSNL $6.81
  • VBNK $19.00
  • AVG Volume (30 Days)
  • PSNL 845.3K
  • VBNK 29.4K
  • Earning Date
  • PSNL 11-06-2024
  • VBNK 12-11-2024
  • Dividend Yield
  • PSNL N/A
  • VBNK 0.45%
  • EPS Growth
  • PSNL N/A
  • VBNK 33.56
  • EPS
  • PSNL N/A
  • VBNK 1.28
  • Revenue
  • PSNL $87,489,000.00
  • VBNK $82,396,676.00
  • Revenue This Year
  • PSNL $14.85
  • VBNK N/A
  • Revenue Next Year
  • PSNL $4.19
  • VBNK $22.69
  • P/E Ratio
  • PSNL N/A
  • VBNK $12.90
  • Revenue Growth
  • PSNL 24.05
  • VBNK 10.81
  • 52 Week Low
  • PSNL $1.02
  • VBNK $7.52
  • 52 Week High
  • PSNL $7.20
  • VBNK $17.06
  • Technical
  • Relative Strength Index (RSI)
  • PSNL 37.60
  • VBNK 64.96
  • Support Level
  • PSNL $4.15
  • VBNK $16.16
  • Resistance Level
  • PSNL $5.40
  • VBNK $17.06
  • Average True Range (ATR)
  • PSNL 0.50
  • VBNK 0.56
  • MACD
  • PSNL -0.10
  • VBNK 0.05
  • Stochastic Oscillator
  • PSNL 3.02
  • VBNK 75.74

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

About VBNK VersaBank

VersaBank is a Canadian Schedule I chartered bank with a difference. VersaBank became the world's first digital financial institution when it adopted its highly efficient business-to-business model using its proprietary state-of-the-art financial technology to profitably address underserved segments of the Canadian banking market in the pursuit of superior net interest margins, while mitigating risk. VersaBank obtains all of its deposits and provides the majority of its loans and leases electronically, with innovative deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, VersaBank established a wholly-owned, subsidiary.

Share on Social Networks: